Not Logged In
Project Navigator
Metformin is taken by roughly 60 million people with an excellent safety record. Animal and observational data hint it may slow aspects of aging and delay age-related disease. The proposed TAME trial (Targeting Aging with Metformin) has struggled for funding precisely because the drug is generic and unpatentable. Open question: in non-diabetic older adults, does metformin delay the onset of age-related conditions versus placebo? Fund a randomized trial to find out.
Pledged: $0.00 |
Committed: $0.00 |
Released: $0.00
Sub-Projects
No projects yet.